Mayo Clinic Q&A: Cardiac Risks of Off-Label Drugs to Treat COVID-19

Everyone
  • 1 video | 15m 50s
Rating 4.7 of 37 users Rating 4.7 of 37 users (37)
A study published recently in Mayo Clinic Proceedings details information about potential cardiac side effects when using off-label drugs to treat COVID-19. Off-label means the drug has been approved by the Food and Drug Administration to treat a different condition. Some of the off-label drugs being used to treat COVID-19 have a risk of sudden cardiac arrest and death. (Published 04/08/2020)

YOU MIGHT ALSO LIKE

PEOPLE WHO VIEWED THIS ALSO VIEWED THESE

Rating 4.4 of 38 users Rating 4.4 of 38 users (38)
Rating 4.6 of 19 users Rating 4.6 of 19 users (19)
Rating 4.9 of 49 users Rating 4.9 of 49 users (49)